Paul Fry
Director/Board Member chez AVACTA GROUP PLC
Profil
Paul Andrew Fry is currently an Independent Non-Executive Director at Avacta Group Plc, and a Director at Vectura Ltd., Vectura Group Services Ltd., and Vectura Delivery Devices Ltd.
He is also a Member of The Chartered Institute of Management Accountants.
Previously, he was the Chief Financial Officer & Executive Director at Vectura Group Ltd.
from 2019 to 2022.
He was also a Director-Global Finance Operations at Vodafone Group Plc, and the Chief Financial Officer at GlaxoSmithKline SpA, Immunocore Holdings Plc, and Immunocore Ltd.
Additionally, he was a Director at Quadrant Healthcare Ltd.
Mr. Fry received his undergraduate degree from the University of Oxford in 1988.
Postes actifs de Paul Fry
| Sociétés | Poste | Début |
|---|---|---|
| AVACTA GROUP PLC | Director/Board Member | 03/02/2020 |
Vectura Delivery Devices Ltd.
 Vectura Delivery Devices Ltd. BiotechnologyHealth Technology Part of Philip Morris International, Inc., Vectura Delivery Devices Ltd. is a British company that engages in research, development and commercialisation of pharmaceutical products. The private company is based in Cambridge, UK and was founded in 2000. | Director/Board Member | 30/06/2019 |
Vectura Group Services Ltd.
 Vectura Group Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Philip Morris International, Inc., Vectura Group Services Ltd. provides business support services. The private company is based in London, UK. | Director/Board Member | 30/06/2019 |
Vectura Ltd.
 Vectura Ltd. Medical SpecialtiesHealth Technology Part of Philip Morris International, Inc., Vectura Ltd. is a leading inhalation CDMO that provides innovative inhaled drug development solutions to help bring medicines to market. The private company is based in Chippenham, UK, and has planning permission for a new 10,000-square meter facility on Bristol & Bath Science Park - inhalation center of excellence. Vectura is reimagining healthcare and self-care, transforming the lives of airways disease patients. Founded in 1983, the British company specializes in formulation science, device technology, and inhaled development expertise to bring DPI, PMDI, and nebulizer medicines to market. | Director/Board Member | 30/06/2019 |
The Chartered Institute of Management Accountants
 The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Corporate Officer/Principal | - |
Anciens postes connus de Paul Fry
| Sociétés | Poste | Fin |
|---|---|---|
| VECTURA GROUP | Chief Executive Officer | 07/11/2019 |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Director of Finance/CFO | - |
| VODAFONE GROUP PLC | Corporate Officer/Principal | - |
| IMMUNOCORE HOLDINGS PLC | Director of Finance/CFO | - |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Paul Fry
| University of Oxford | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| VODAFONE GROUP PLC | Communications |
| AVACTA GROUP PLC | Commercial Services |
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| Entreprise privées | 8 |
|---|---|
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Consumer Services |
GlaxoSmithKline SpA
 GlaxoSmithKline SpA Pharmaceuticals: MajorHealth Technology GlaxoSmithKline SpA manufactures and distributes pharmaceutical products. The firm offers prescription pharmaceuticals and vaccines, over-the-counter medicines, oral care and nutritional healthcare products. The company was founded on March 30, 1932 and is headquartered in Verona, Italy. | Health Technology |
Vectura Ltd.
Vectura Ltd. Medical SpecialtiesHealth Technology Part of Philip Morris International, Inc., Vectura Ltd. is a leading inhalation CDMO that provides innovative inhaled drug development solutions to help bring medicines to market. The private company is based in Chippenham, UK, and has planning permission for a new 10,000-square meter facility on Bristol & Bath Science Park - inhalation center of excellence. Vectura is reimagining healthcare and self-care, transforming the lives of airways disease patients. Founded in 1983, the British company specializes in formulation science, device technology, and inhaled development expertise to bring DPI, PMDI, and nebulizer medicines to market. | Health Technology |
Vectura Group Services Ltd.
Vectura Group Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Philip Morris International, Inc., Vectura Group Services Ltd. provides business support services. The private company is based in London, UK. | Commercial Services |
Vectura Delivery Devices Ltd.
Vectura Delivery Devices Ltd. BiotechnologyHealth Technology Part of Philip Morris International, Inc., Vectura Delivery Devices Ltd. is a British company that engages in research, development and commercialisation of pharmaceutical products. The private company is based in Cambridge, UK and was founded in 2000. | Health Technology |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The private company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Health Technology |
Quadrant Healthcare Ltd.
 Quadrant Healthcare Ltd. Financial ConglomeratesFinance Founded in 1995, Quadrant Healthcare Ltd. is a subsidiary of Philip Morris International, Inc. and functions as an investment holding British company. The private company is based in Chippenham, UK. | Finance |
